Search

Displaying results 6871 - 6880 of 9333 in total
  1. Drug

    LX6171

    go.drugbank.com/drugs/DB05180
    Investigational

    LX6171 is an oral drug candidate that was generated by Lexicon medicinal chemists and is being developed to treat disorders characterized by cognitive impairment, such as Alzheimer's disease, schizophrenia

  2. Drug

    ST-36

    go.drugbank.com/drugs/DB17275
    Experimental

    In 2017, it received orphan drug designation by the FDA for the treatment of glioma.[L47341]

  3. Drug

    BN‐Brachyury vaccine

    go.drugbank.com/drugs/DB17425
    Experimental

    It is composed of the [MVA-BN-brachyury-TRICOM vaccine] and the fowlpox virus(FPV)‐Brachyury booster vaccine.[A255173]

  4. Drug

    JNJ-26489112

    go.drugbank.com/drugs/DB15203
    Investigational

    JNJ-26489112 is under investigation in clinical trial NCT00579384 (A Study of the Effects of JNJ-26489112 on the Photic Induced Paroxysmal Electroencephalogram (EEG) Response in Patients With Photosensitive

  5. Drug

    Resiniferatoxin

    go.drugbank.com/drugs/DB06515
    Investigational

    Resiniferatoxin (RTX) is a naturally occurring, ultrapotent capsaicin analog that activates the vanilloid receptor in a subpopulation of primary afferent sensory neurons involved in nociception (the transmission

  6. Drug

    Bapineuzumab

    go.drugbank.com/drugs/DB11715
    Investigational

    Bapineuzumab has been investigated for the treatment of Alzheimer's Disease.

  7. Drug

    Pefcalcitol

    go.drugbank.com/drugs/DB11786
    Investigational

    Pefcalcitol has been investigated for the basic science of Psoriasis.

  8. Drug

    Bi104

    go.drugbank.com/drugs/DB18743
    Experimental

    Bi104 is being investigated for the treatment of Angelman syndrome.

  9. Drug

    Doxifluridine

    go.drugbank.com/drugs/DB12947
    Investigational

    Doxifluridine has been investigated for the treatment of Stomach Cancer.

  10. Drug

    Saroglitazar

    go.drugbank.com/drugs/DB13115
    Investigational

    Saroglitazar has been investigated for the treatment of Fatty Liver.